IPP Bureau
Sudeep Pharma eyes Rs. 895 crore fundraising from debut on bourses
By IPP Bureau - November 19, 2025
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
Cardiol Therapeutics wins US patent protection for heart-disease drug platform
By IPP Bureau - November 19, 2025
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
Meduloc wins FDA green light for new class of bone-fracture fixation system
By IPP Bureau - November 19, 2025
The cleared system pairs a flexible nitinol implant with a deployable prong-locking mechanism, delivering rotational and length stability
Roche’s Giredestrant sets new benchmark in early breast cancer treatment
By IPP Bureau - November 19, 2025
The study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in invasive disease-free survival
.png "Time Medical launches India’s first low-field TOF MRI for nationwide aneurysm screening")
Time Medical launches India’s first low-field TOF MRI for nationwide aneurysm screening
By IPP Bureau - November 19, 2025
India presents one of the world’s largest untapped opportunities for neurovascular screening
HRV Pharma and MetroChem forge CDMO alliance to fast-track NCE-1 API development
By IPP Bureau - November 19, 2025
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
Evonik and InVitria form strategic partnership to supply animal-free albumin to global biopharma market
By IPP Bureau - November 18, 2025
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Kingsway Pharma acquires minority stake in CIGA Healthcare to boost US diagnostic access
By IPP Bureau - November 18, 2025
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Galmed’s Aramchol shows promise in overcoming gastrointestinal cancer drug resistance
By IPP Bureau - November 18, 2025
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Merus and Halozyme collaborate to advance subcutaneous Petosemtamab development
By IPP Bureau - November 18, 2025
Merus has licensed Halozyme’s proprietary ENHANZE technology to develop and commercialize subcutaneous formulations of petosemtamab
Ingenus Pharma launches first FDA-approved generic version of Premarin
By IPP Bureau - November 18, 2025
Conjugated Estrogens Tablets are indicated for moderate to severe menopausal symptoms, including hot flashes, and for the prevention of postmenopausal osteoporosis in women at significant risk
New England Biolabs unveils high-speed flu sequencing tool to bolster global outbreak surveillance
By IPP Bureau - November 18, 2025
Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
Akums launches 14th free plastic surgery camp in Haridwar
By IPP Bureau - November 18, 2025
The ten-day initiative, running from 10 to 21 November, brings together a team of highly skilled German doctors providing life-changing reconstructive surgeries at no cost
XenoTherapeutics to acquire Repare Therapeutics
By IPP Bureau - November 17, 2025
